Nutriband Inc. NTRB

NTRB Company Overview

Nutriband Inc. is a U.S.-based pharmaceutical and transdermal drug delivery company focused on the development of abuse-deterrent transdermal therapeutic systems and other prescription pharmaceutical products. The company operates within the specialty pharmaceutical and drug delivery industries, with an emphasis on leveraging transdermal technologies to improve patient compliance, safety, and controlled drug administration. Nutriband’s primary strategic focus has been the development of opioid abuse-deterrent technologies for pain management applications.

The company’s principal revenue and value drivers have centered on intellectual property development, pharmaceutical product licensing opportunities, and collaborative commercialization arrangements. Nutriband is best known for its AVERSA abuse-deterrent technology platform, designed to reduce misuse, abuse, and accidental exposure of transdermal opioid patches. The company has also been involved in contract manufacturing and nutraceutical-related operations historically, though its strategic direction has increasingly emphasized pharmaceutical development. Public filings and investor materials indicate that Nutriband evolved from earlier nutraceutical and consumer health activities into a more focused specialty pharmaceutical company through acquisitions, technology licensing, and internal product development initiatives.